COMMUNIQUÉS West-GlobeNewswire

Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
06/05/2025
-- Data will be featured at EULAR Annual Congress – BRISBANE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid [...]
Actuate Therapeutics Announces Statistically Significant Topline Results from Global Phase 2 Trial of Elraglusib in First-Line Treatment of Metastatic Pancreatic Cancer
06/05/2025
Topline data shows statistically significant improvement in overall survival in elraglusib plus GnP combination arm versus GnP control arm Elraglusib/GnP combination arm demonstrated substantial improvement in median [...]
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
06/05/2025
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) and Elevated Markers of Cardiac Stress Dr. Amish Raval, Professor of [...]
Cogent Biosciences Reports First Quarter 2025 Financial Results
06/05/2025
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year [...]
Galimedix Therapeutics completes single ascending dose part of Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
06/05/2025
GAL-101 well tolerated; excellent safety and pharmacokinetic profile strongly supports oral administration Next arms of study, including multiple ascending dose (MAD), underway and expected to complete in late 2025 [...]
Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
06/05/2025
- FDA RMAT designation recognizes encouraging early data from Opus’ Phase 1/2 trial in patients with LCA5, an ultra-rare inherited retinal disease RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus [...]
VAXIL: SHARE CONSOLIDATION
06/05/2025
Not for distribution by US newswire or in United States TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the [...]
The 4 Best Male Enhancement Pills to Buy OTC, In Stores & Online 2025: Top Sex Pills for Men's Sexual Performance Over the Counter - Leading Edge Health
06/05/2025
Limassol, Cyprus, May 06, 2025 (GLOBE NEWSWIRE) -- The top male enhancement pills for 2025 is presented by Leading Edge Health Finding the best male enhancement pill can feel overwhelming with so many options available [...]
ProstaVive Side Effects & Complaints EXPOSED: Real Review Backed by ProstaVive Users’ Experiences!
06/05/2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Thinking about trying ProstaVive to support your prostate health, energy, and overall wellness? You're definitely not alone. This natural supplement has been generating a lot [...]
Mind Lab PRO Under Review: Is Mind Lab Pro® v4.0 Universal Nootropic Brain Booster Safe? Best Nootropics Supplement
06/05/2025
Uncover the truth about Mind Lab Pro® v4.0. Is this universal nootropic safe and effective? Full review of its brain-boosting benefits, ingredients, and real user results Royal Leamington Spa, May 06, 2025 (GLOBE [...]
Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera
06/05/2025
MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV [...]
ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer
06/05/2025
MELBOURNE, Australia, May 06, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory , a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral respiratory infections, [...]
NTG Nordic Transport Group A/S - Q1 2025 Conference Call
06/05/2025
NTG Nordic Transport Group A/S – Q1 2025 Conference Call We expect to release the Q1 2025 results of NTG Nordic Transport Group in the evening of May 12, 2025. A webcast and conference call will be held in the morning [...]
New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease
06/05/2025
Two-year data from England’s National Health Service show improved care efficiency with reduction in unnecessary invasive and noninvasive cardiac tests using CCTA and Heartflow FFRCT versus CCTA alone MOUNTAIN VIEW, [...]
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
06/05/2025
Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of [...]
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
06/05/2025
Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis, France and Dublin, Ireland – 6 th May 2025 – Priothera Ltd., a late-stage biopharma [...]
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines
06/05/2025
Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026 COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the [...]
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
06/05/2025
Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the [...]
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
06/05/2025
PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy & Transformation, [...]

Pages